01/19/2021 3:02 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2021 6:31 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2021 10:43 AM | Atara Biotherapeutics (Subject) JPMORGAN CHASE & CO (Filed by)
| Form SC 13G
| |
12/18/2020 5:35 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2020 5:32 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4/A
| |
12/09/2020 4:08 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2020 4:07 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
12/07/2020 3:28 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
12/07/2020 7:26 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2020 3:08 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
11/18/2020 3:07 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 3:07 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 3:19 PM | Atara Biotherapeutics (Issuer) Atara Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2020 3:41 PM | Atara Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/09/2020 3:11 PM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/09/2020 3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2020 6:39 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2020 6:38 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2020 6:37 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2020 3:18 PM | Atara Biotherapeutics (Issuer) Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 8:15 PM | Atara Biotherapeutics (Issuer) SEIDENBERG BETH C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:46 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:46 PM | Atara Biotherapeutics (Issuer) Gallagher Carol Giltner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:45 PM | Atara Biotherapeutics (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:44 PM | Atara Biotherapeutics (Issuer) DOBMEIER ERIC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:43 PM | Atara Biotherapeutics (Issuer) Baynes Roy D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/27/2020 4:27 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
05/20/2020 5:11 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:11 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:10 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2020 6:17 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2020 6:16 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/30/2020 6:44 PM | Atara Biotherapeutics (Issuer) Renaud Ronald C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2020 6:43 PM | Atara Biotherapeutics (Issuer) Renaud Ronald C JR (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/30/2020 4:25 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/21/2020 3:17 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2020 3:16 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/07/2020 3:21 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2020 7:46 AM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
02/27/2020 6:47 AM | Atara Biotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/27/2020 6:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/19/2020 7:53 PM | Atara Biotherapeutics (Issuer) Yarema Kristin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/19/2020 7:50 PM | Atara Biotherapeutics (Issuer) Yarema Kristin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/10/2020 6:48 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2020 6:47 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2020 10:26 AM | Atara Biotherapeutics (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A
| |
01/28/2020 3:31 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2019 6:51 AM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019 6:40 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2019 3:12 PM | Atara Biotherapeutics (Subject) BRIDGER MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
10/25/2019 4:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2019 3:25 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2019 9:20 AM | Atara Biotherapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A
| |
08/08/2019 6:51 AM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019 6:40 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/29/2019 1:27 PM | Atara Biotherapeutics (Subject) Camber Capital Management LP (Filed by)
| Form SC 13G
| |
07/22/2019 4:15 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2019 4:25 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
07/18/2019 3:07 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
07/01/2019 4:58 PM | Atara Biotherapeutics (Issuer) SEIDENBERG BETH C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2019 4:01 PM | Atara Biotherapeutics (Issuer) DOBMEIER ERIC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2019 4:00 PM | Atara Biotherapeutics (Issuer) Gallagher Carol Giltner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2019 4:00 PM | Atara Biotherapeutics (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2019 3:59 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2019 3:58 PM | Atara Biotherapeutics (Issuer) Baynes Roy D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2019 3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2019 3:20 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2019 3:19 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/05/2019 5:04 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2019 3:16 PM | Atara Biotherapeutics (Issuer) Ciechanover Isaac E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2019 4:00 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2019 7:25 AM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019 7:10 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2019 3:32 PM | Atara Biotherapeutics (Issuer) Berger Dietmar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2019 3:31 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2019 3:35 PM | Atara Biotherapeutics (Filer)
| Form DEFA14A
| |
04/29/2019 4:36 PM | Atara Biotherapeutics (Issuer) Ciechanover Isaac E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2019 3:19 PM | Atara Biotherapeutics (Issuer) Ciechanover Isaac E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2019 3:33 PM | Atara Biotherapeutics (Issuer) Kim Mina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2019 6:22 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2019 3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2019 3:16 PM | Atara Biotherapeutics (Issuer) Ciechanover Isaac E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2019 3:16 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4/A
| |
03/27/2019 4:19 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2019 4:18 PM | Atara Biotherapeutics (Issuer) Kim Mina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2019 4:18 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2019 4:17 PM | Atara Biotherapeutics (Issuer) Berger Dietmar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2019 4:17 PM | Atara Biotherapeutics (Issuer) Porter Derrell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2019 3:19 PM | Atara Biotherapeutics (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2019 11:59 AM | Atara Biotherapeutics (Filer)
| Form CT ORDER
| |
03/05/2019 5:58 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2019 3:09 PM | Atara Biotherapeutics (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2019 3:08 PM | Atara Biotherapeutics (Issuer) MARCUS JOEL S (Reporting)
| Form 4/A
| |
02/26/2019 7:55 AM | Atara Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2019 7:52 AM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
02/26/2019 7:47 AM | Atara Biotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/26/2019 6:41 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2019 9:14 AM | Atara Biotherapeutics (Subject) Camber Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/14/2019 6:53 AM | ArrowMark Colorado Holdings LLC (Filed by) Atara Biotherapeutics (Subject)
| Form SC 13G/A
| |
02/12/2019 6:18 PM | Atara Biotherapeutics (Issuer) Ciechanover Isaac E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |